Min Li
- Cancer Research top 0.5%
- MicroRNA in disease regulation 36
- Cancer-related molecular mechanisms research 33
- Microbiology top 0.5%
- Antimicrobial Peptides and Activities 21
- Molecular Biology top 1%
- Circular RNAs in diseases 30
- RNA modifications and cancer 20
- Immunology top 1%
- Immune Response and Inflammation 21
- Dermatology top 0.5%
- Dermatology and Skin Diseases 19
-
- Antifungal resistance and susceptibility 17
- Co-authors
- Michaël OttoAmer E. VillaruzYuping LaiDaniel E. SturdevantJ. C. DavidChangyi ChenQizhi YaoXu Chen
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Min Li
589 papers receiving 12.1k citations
Hit Papers
Peers
Comparison fields: 5 of 192
- Cancer Research 2.0k
- Microbiology 610
- Molecular Biology 6.0k
- Immunology 1.6k
- Dermatology 576
Countries citing papers authored by Min Li
This map shows the geographic impact of Min Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Li more than expected).
Fields of papers citing papers by Min Li
This network shows the impact of papers produced by Min Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Li. The network helps show where Min Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 0 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 58 | |
| 13 | 2023 | 0 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2023 | 7 | |
| 17 | 2023 | 9 | |
| 18 | 2022 | 17 | |
| 19 | 2019 | 25 | |
| 20 | 2015 | 62 |
About Min Li
Min Li is a scholar working on Cancer Research, Dermatology and Immunology, having authored 642 papers that have together received 12.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (36 papers), Cancer-related molecular mechanisms research (33 papers), Circular RNAs in diseases (30 papers), Antimicrobial Peptides and Activities (21 papers), Immune Response and Inflammation (21 papers), RNA modifications and cancer (20 papers), Dermatology and Skin Diseases (19 papers) and Antifungal resistance and susceptibility (17 papers). The work is most often cited by research in Cancer Research (2.0k citations), Microbiology (610 citations) and Molecular Biology (6.0k citations). Min Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Michaël Otto, Amer E. Villaruz, Yuping Lai, Daniel E. Sturdevant, J. C. David, Changyi Chen, Qizhi Yao, Xu Chen, Uddalak Bharadwaj and Yaping Guo. Their work appears in journals such as PLoS ONE, Oncotarget, Cell Death and Disease, Journal of Photochemistry and Photobiology B Biology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.